Harrison W. Farber

19.1k citations

254 papers · 13.5k indexed · 7 hit papers · h-index 52

Impact in

Pulmonary and Respiratory Medicine top 0.05%
- Pulmonary Hypertension Research and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Cardiology and Cardiovascular Medicine top 0.2%
- Cardiovascular Issues in Pregnancy
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management

Papers in

Pulmonary and Respiratory Medicine 159
- Pulmonary Hypertension Research and Treatments 147
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 26
Genetics 41
- Vascular Anomalies and Treatments 28

Co-authors: Joseph Loscalzo Michael D. McGoon David B. Badesch Robyn J. Barst Raymond L. Benza Dave P. Miller Vallerie V. McLaughlin Adaani Frost
Journals: CHEST Journal (37 papers)The Journal of Heart and Lung Transplantation (26 papers)Pulmonary Circulation (16 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (6 papers)American Journal of Respiratory and Critical Care Medicine (6 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Harrison W. Farber

243 papers receiving 13.2k citations

Hit Papers

7 papers align trajectories log scale

Predicting Survival in Patients With Pulmonary Arterial Hypertension 2019 · 390 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 CHEST Journal
2015 CHEST Journal
2009 Circulation
2009 CHEST Journal
2009 Journal of the American College of Cardiology
2004 New England Journal of Medicine
1987 New England Journal of Medicine

Peers

Countries citing papers authored by Harrison W. Farber

Since Specialization

Citations

This map shows the geographic impact of Harrison W. Farber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harrison W. Farber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harrison W. Farber more than expected).

Fields of papers citing papers by Harrison W. Farber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harrison W. Farber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harrison W. Farber. The network helps show where Harrison W. Farber may publish in the future.

Co-authors

The 25 scholars most cited alongside Harrison W. Farber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Harrison W. Farber Line = papers co-authored together Harrison W. Farber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity Journal of Racial and Ethnic Health Disparities ·Harrison W. Farber, Murali M. Chakinala, Anna R. Hemnes, Kelly Chin, Kristin B. Highland, Vallerie V. McLaughlin, R. Maizi, Michelle Cho, G I Zelada, Zh.T. Kusbergenova, 陆小花, Mohammad A. Rahman, Г В Точильников, Tobore Onojighofia Tobore, Nick H. Kim	2025	0
2	Sotatercept to Wean Off Prostacyclin Infusion Therapy for Pulmonary Arterial Hypertension: A Case Report Pulmonary Circulation ·Melissa Brust, Moritz Dominik, M. Catherine Bennett, Ioana R. Preston, Harrison W. Farber, Nicholas S. Hill	2025	0
3	Severe pulmonary hypertension–interstitial lung disease presenting as right ventricular failure: stabilisation with intravenous prostacyclin and maintenance with inhaled prostacyclin ERJ Open Research ·雄一郎源, Alan Thomas, Bogdan Pieczonka, Carlos Chirinos, Jadranka Ivanova, Harrison W. Farber	2024	2
4	Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States Pulmonary Circulation ·Harrison W. Farber, Hayley D. Germack, Nicole S. Croteau, Jason C. Simeone, Fei Tang, Carly J. Paoli, G I Zelada, Sumeet Panjabi, Teresa De Marco	2024	4
5	Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository Pulmonary Circulation ·Harrison W. Farber, Murali M. Chakinala, Michelle Cho, Robert P. Frantz, Dalia S. Morga, Lisa Lancaster, Scott Milligan, Ronald J. Oudiz, Sumeet Panjabi, Yuen Tsang, Steven D. Nathan	2023	3
6	Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry) The Journal of Heart and Lung Transplantation ·Vallerie V. McLaughlin, Harrison W. Farber, Kristin B. Highland, Anna R. Hemnes, Murali M. Chakinala, Kelly Chin, 陆小花, Michelle Cho, Tobore Onojighofia Tobore, Hafizur Rahman, Nick H. Kim	2023	9
7	Patients with systemic sclerosis-associated pulmonary arterial hypertension express a genomic signature distinct from patients with interstitial lung disease Journal of Scleroderma and Related Disorders ·Matthew Moll, Romy Christmann, Yuqing Zhang, Michael L. Whitfield, Chongjian Ke, Lisa Rice, Juma J. Mwabaya, Robert Lafyatis, Harrison W. Farber	2018	11
8	C-arm Positioning Is a Significant Source of Radiation in Spine Surgery Spine ·Yani Sara Bauti, Rupen Desai, Carl Krockel, Harrison W. Farber, Elisabeth Vischer, 優美亀田, Robert E. Isaacs	2016	4
9	Effects of Psoas Muscle Thickness on Outcomes of Lumbar Fusion Surgery World Neurosurgery ·Terence Verla, Owoicho Adogwa, Aladine A. Elsamadicy, 上久保敏, Harrison W. Farber, Joseph Cheng, Carlos A. Bagley	2015	16
10	Impact of advancing age on post-operative complications of deep brain stimulation surgery for essential tremor Journal of Clinical Neuroscience ·Terence Verla, Andrew Marky, Harrison W. Farber, Frank W. Petraglia, John A. Gallis, Yuliya Lokhnygina, Beth Parente, Patrick Hickey, Dennis A. Turner, Shivanand P. Lad	2015	20
11	TREATMENT OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: A PILOT STUDY OF RANOLAZINE CHEST Journal ·Harrison W. Farber, Kirsten Jensen, Juma J. Mwabaya	2013	1
12	ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension Circulation ·Vallerie V. McLaughlin, Stephen L. Archer, David B. Badesch, Robyn J. Barst, Harrison W. Farber, Jonathan R. Lindner, Michael A. Mathier, Michael D. McGoon, Myung H. Park, Robert S. Rosenson, Lewis J. Rubin, Victor F. Tapson, John Varga Hit paper breakdown →	2009	844
13	Outcome after Cardiopulmonary Resuscitation in Patients with Pulmonary Arterial Hypertension American Journal of Respiratory and Critical Care Medicine ·Marius M. Hoeper, Nazzareno Galiè, Srinivas Murali, Horst Olschewski, Melvyn Rubenfire, HU Hui-juan, Harrison W. Farber, Vallerie V. McLaughlin, Shelley Shapiro, Joanna Pepke‐Żaba, J Winkler, Ralf Ewert, Christian Opitz, Volker Westerkamp, Jean-Luc Vachiéry, Adam Torbicki, J Behr, Robyn J. Barst	2002	114
14	Increased F2 Isoprostanes in the Acute Chest Syndrome of Sickle Cell Disease as a Marker of Oxidative Stress American Journal of Respiratory and Critical Care Medicine ·Elizabeth S. Klings, Brian W. Christman, James P. McClung, Arthur F. Stucchi, Lillian McMahon, Walace Hawkins, Harrison W. Farber	2001	37
15	Epoprostenol (Prostacyclin) Therapy in HIV-associated Pulmonary Hypertension American Journal of Respiratory and Critical Care Medicine ·RICHARD GARCIA, Harrison W. Farber	2000	125
16	Endotracheal Reintubation: A Closer Look at a Preventable Condition Clinical Nurse Specialist ·Kaitlin E. Callahan, John Bernardo, А. Г. Мармыш, Soichi Takeishi, 松田広, H. Kalakhety, Fawaz Salim Yousif, Harrison W. Farber	1997	7
17	Endothelin-1 Production during the Acute Chest Syndrome in Sickle Cell Disease American Journal of Respiratory and Critical Care Medicine ·坂口律子, Stella Kourembanas, О.С. Сухарев, Marisa Tucci, Mark J. Brauer, Harrison W. Farber	1997	88
18	Rifampin Preventive Therapy for Tuberculosis in Boston's Homeless American Journal of Respiratory and Critical Care Medicine ·Andrea Polesky, Harrison W. Farber, Daniel J. Gottlieb, Smrithi Menon, Samuel A. Levinson, James J. O’Connell, 谭晓晨, 信邦三潴, John Bernardo	1996	60
19	Non-neuronal Enolase Is an Endothelial Hypoxic Stress Protein Journal of Biological Chemistry ·Serge L. Smirnov, Krista K. Graven, Marisa Tucci, Robert J. McDonald, Harrison W. Farber	1995	133
20	Pulmonary Response to Foreign Body Microemboli in Dogs: Release of Neutrophil Chemoattractant Activity by Vascular Endothelial Cells American Journal of Respiratory Cell and Molecular Biology ·Harrison W. Farber, R. Paul Fairman, G. Fillingham, Sharon Rounds, Frederick L. Glauser	1989	8

About Harrison W. Farber

Harrison W. Farber is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Cardiology and Cardiovascular Medicine, Hepatology and Internal Medicine, having authored 254 papers that have together received 13.5k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (147 papers), Cardiovascular Issues in Pregnancy (31 papers), Heart Failure Treatment and Management (30 papers), Vascular Anomalies and Treatments (28 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (26 papers), Nitric Oxide and Endothelin Effects (19 papers), Cardiovascular Function and Risk Factors (19 papers) and Liver Disease and Transplantation (17 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (9.1k citations), Cardiology and Cardiovascular Medicine (5.7k citations), Genetics (1.9k citations), Critical Care and Intensive Care Medicine (570 citations) and Hepatology (812 citations). Harrison W. Farber has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Joseph Loscalzo, Michael D. McGoon, David B. Badesch, Robyn J. Barst, Raymond L. Benza, Dave P. Miller, Vallerie V. McLaughlin, Adaani Frost, Lewis J. Rubin and Michael A. Mathier. Their work appears in journals such as CHEST Journal, The Journal of Heart and Lung Transplantation, Pulmonary Circulation, American Journal of Physiology-Lung Cellular and Molecular Physiology and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact